Eric Coldwell Baird Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
46
Avg Return
Past Year
Past Year
12%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
39.1%
Neutral
60.9%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Materials
Real Estate
Healthcare
Biotechnology
Diagnostics & Research
Drug Manufacturers - General
Healthcare Plans
Health Information Services
Medical Devices
Medical Distribution
Pharmaceutical Retailers
Materials
Specialty Chemicals
Real Estate
Diversified REIT
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Maintained
| $14 |
35%
upside
| 5 | +23% |
0
%
| 3 Sep ‘25 1 month ago |
|
|
|
Outperform
Maintained
| $224 |
16%
upside
| 7 | +7.3% |
0
%
| 2 Sep ‘25 1 month ago |
|
|
|
Neutral
Downgraded
| $194 |
5%
upside
| 4 | +4.6% |
0
%
| 25 Aug ‘25 1 month ago |
|
|
|
Neutral
Maintained
| $27 |
4%
downside
| 4 | – |
–
| 20 Aug ‘25 2 months ago |
|
|
|
Outperform
Maintained
| $203 |
28%
upside
| 2 | +4.5% |
0
%
| 13 Aug ‘25 2 months ago |
|
|
|
Outperform
Maintained
| $7 |
38%
upside
| 6 | +9.3% |
0
%
| 12 Aug ‘25 2 months ago |
|
|
|
Outperform
Maintained
| $302 |
6%
upside
| 3 | +7.3% |
0
%
| 25 Jul ‘25 2 months ago |
|
|
|
Neutral
Maintained
| $490 |
10%
downside
| 5 | – |
–
| 23 Jul ‘25 3 months ago |
|
|
|
Neutral
Maintained
| $196 |
10%
downside
| 5 | – |
–
| 23 Jul ‘25 3 months ago |
|
|
|
Neutral
Maintained
| $140 |
26%
downside
| 2 | – |
–
| 8 May ‘25 5 months ago |
|
|
|
Outperform
Maintained
| $16 |
66%
upside
| 2 | +3.8% |
0
%
| 27 Feb ‘25 7 months ago |
|
|
|
Outperform
Upgraded
| $688 |
13%
downside
| 1 | +43% |
0
%
| 7 Nov ‘24 11 months ago |
|